This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors | MicrobiomeTrials
← Back to trials NCT07664176
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09Est. Completion: 2030-12
Enrollment target: 30 participantsLocations Children's National Hospital, Washington D.C., District of Columbia, United States Other microbiome trials you might be interested in Malignant Glioma
This phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radi…
Birmingham, United States Est. completion Jun 30, 2027
Diffuse Midline Glioma Diffuse Midline High-grade Glioma Medulloblastoma Ependymoma
This is a multisite, phase I/II clinical trial in children and young adults with newly-diagnosed high-grade glioma (HGG)…
St Louis, United States Completed Aug 31, 2031
Diffuse Midline Glioma, H3 K27-Altered Metastatic Malignant Neoplasm in the Central Nervous System Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Diffuse Midline Glioma, H3 K27-Altered Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Primary Malignant Central Nervous System Neoplasm Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Primary Malignant Central Nervous System Neoplasm
This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with so…
Birmingham, United States Est. completion Dec 31, 2026